In-Silico Structure Database (LMISSD)
BackLMISSD: Lipid Classification search results
Fatty Acyls [FA](W) --> Docosanoids [FA04] --> Neuroprostanes [FA0401]
LM_ID | Common Name | Systematic Name | Formula | Mass |
---|---|---|---|---|
LMFA04010354 | ent-14-epi-14-E4t-NeuroP | (Z)-6-((1S,2R,3S)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010355 | 14-epi-14-E4c-NeuroP | (Z)-6-((1R,2S,3R)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010356 | 7,14-diepi-14-E4t-NeuroP | (Z)-6-((1R,2R,3R)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010357 | 7,14-diepi-14-E4c-NeuroP | (Z)-6-((1S,2S,3R)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010358 | 14-epi-14-E4t-NeuroP | (Z)-6-((1S,2R,3R)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010359 | 14-E4c-NeuroP | (Z)-6-((1R,2S,3R)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010360 | 7-epi-14-E4t-NeuroP | (Z)-6-((1R,2R,3R)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010361 | 7-epi-14-E4c-NeuroP | (Z)-6-((1S,2S,3R)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010362 | 14-E4t-NeuroP | (Z)-6-((1S,2R,3R)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid | C22H32O5 | 376.2250 |
LMFA04010363 | ent-17-E4t-NeuroP | (4Z,7Z)-9-((1R,2S,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010364 | ent-10-epi-17-E4c-NeuroP | (4Z,7Z)-9-((1R,2R,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010365 | ent-10-epi-17-E4t-NeuroP | (4Z,7Z)-9-((1S,2S,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010366 | ent-17-E4c-NeuroP | (4Z,7Z)-9-((1S,2R,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010367 | ent-17-epi-17-E4t-NeuroP | (4Z,7Z)-9-((1R,2S,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010368 | ent-10,17-diepi-17-E4c-NeuroP | (4Z,7Z)-9-((1R,2R,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010369 | ent-10,17-diepi-17-E4t-NeuroP | (4Z,7Z)-9-((1S,2S,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010370 | ent-17-epi-17-E4t-NeuroP | (4Z,7Z)-9-((1S,2R,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010371 | 17-epi-17-E4c-NeuroP | (4Z,7Z)-9-((1R,2S,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010372 | 10,17-diepi-17-E4t-NeuroP | (4Z,7Z)-9-((1R,2R,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010373 | 10,17-diepi-17-E4c-NeuroP | (4Z,7Z)-9-((1S,2S,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010374 | 17-epi-17-E4t-NeuroP | (4Z,7Z)-9-((1S,2R,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010375 | 17-E4c-NeuroP | (4Z,7Z)-9-((1R,2S,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010376 | 10-epi-17-E4t-NeuroP | (4Z,7Z)-9-((1R,2R,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010377 | 10-epi-17-E4c-NeuroP | (4Z,7Z)-9-((1S,2S,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010378 | 17-E4t-NeuroP | (4Z,7Z)-9-((1S,2R,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid | C22H32O5 | 376.2250 |
LMFA04010379 | ent-20-E4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,3S)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010380 | ent-13-epi-20-E4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,3S)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010381 | ent-13-epi-20-E4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,3S)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010382 | ent-20-E4c-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,3S)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010383 | ent-20-epi-20-E4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,3S)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010384 | ent-13,20-diepi-20-E4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,3S)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010385 | ent-13,20-diepi-20-E4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,3S)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010386 | ent-20-epi-20-E4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,3S)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010387 | 20-epi-20-E4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,3R)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010388 | 13,20-diepi-20-E4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,3R)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010389 | 13,20-diepi-20-E4c-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,3R)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010390 | 20-epi-20-E4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,3R)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010391 | 20-E4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,3R)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010392 | 13-epi-20-E4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010393 | 13-epi-20-E4c-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,3R)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010394 | 20-E4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid | C22H32O5 | 376.2250 |
LMFA04010395 | 4-epi-4-A4-NeuroP | (R,E)-4-hydroxy-6-((1R,5R)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid | C22H30O4 | 358.2144 |
LMFA04010396 | ent-7-epi-4-A4-NeuroP | (R,E)-4-hydroxy-6-((1R,5S)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid | C22H30O4 | 358.2144 |
LMFA04010397 | 4,7-diepi-4-A4-NeuroP | (R,E)-4-hydroxy-6-((1S,5R)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid | C22H30O4 | 358.2144 |
LMFA04010398 | ent-4-A4-NeuroP | (R,E)-4-hydroxy-6-((1S,5S)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid | C22H30O4 | 358.2144 |
LMFA04010399 | 4-A4-NeuroP | (S,E)-4-hydroxy-6-((1R,5R)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid | C22H30O4 | 358.2144 |
LMFA04010400 | ent-4,7-diepi-4-A4-NeuroP | (S,E)-4-hydroxy-6-((1R,5S)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid | C22H30O4 | 358.2144 |
LMFA04010401 | 7-epi-4-A4-NeuroP | (S,E)-4-hydroxy-6-((1S,5R)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid | C22H30O4 | 358.2144 |
LMFA04010402 | ent-4-epi-4-A4-NeuroP | (S,E)-4-hydroxy-6-((1S,5S)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid | C22H30O4 | 358.2144 |
LMFA04010403 | 7-epi-7-A4-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,2R)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid | C22H30O4 | 358.2144 |